The Nucleic Acid Therapy Accelerator (NATA) is a new national research initiative with a mission to accelerate the development of nucleic acid therapeutics, while firmly anchoring the nucleic acid (NA) therapy industry in the UK for many years to come. 

The NATA will be at the Harwell Science and Innovation Campus, at the heart of a growing Life Health Cluster. It will benefit from and contribute to the campus’ world-class scientific talent, ecosystem and related facilities, including the Research Complex at Harwell and the new Rosalind Franklin Institute.

Life Sciences

Research

Therapeutics

NATA - Nucleic Acid Therapy Accelerator

Nick Lench

Anne Willis

Alison Smith

Shalini Andersson

Laura Sepp - Lorenzino

The Leadership Team at Nucleic Acid Therapy Accelerator (NATA) comprises high-profile scientific and industry experts responsible for guiding the strategic direction of the initiative. Their task is to leverage their expertise and networks to foster innovation, drive research initiatives, and establish collaborations that ensure NATA remains at the forefront of nucleic acid therapeutics development. They aim to position the UK as a global leader in the NA therapy industry by overseeing the integration of cutting-edge science and industry demands.

Leadership Team

Research and Development Team

Leadership Team

About

Team members

Other teams at NATA - Nucleic Acid Therapy Accelerator

Research and Development Team